PROCEPT BioRobotics (PRCT) Research & Development (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Research & Development data on file, last reported at $21.5 million in Q1 2026.

• On a quarterly basis, Research & Development rose 30.87% year-over-year to $21.5 million in Q1 2026; TTM through Mar 2026 was $76.3 million, a 16.34% increase from a year earlier, with the FY2025 full-year figure at $71.3 million, up 14.41% from the prior year.
• Research & Development for Q1 2026 stood at $21.5 million, up from $19.1 million in the prior quarter.
• Over the last five years, Research & Development for PRCT reached as high as $21.5 million in Q1 2026 and fell as low as $5.0 million in Q1 2022.
• Historically, Research & Development has averaged $13.7 million across 5 years, with a median of $14.5 million in 2023.
• Across the five-year window, Research & Development soared 114.27% in 2023 and advanced 0.75% in 2025, its largest moves.
• Year by year, Research & Development stood at $9.7 million in 2022, then surged by 49.72% to $14.5 million in 2023, then rose by 3.93% to $15.1 million in 2024, then gained by 26.48% to $19.1 million in 2025, then grew by 12.64% to $21.5 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $21.5 million in Q1 2026, $19.1 million in Q4 2025, and $18.2 million in Q3 2025.